ClinicalTrials.gov
ClinicalTrials.gov Menu

Investigating Safety, Tolerability and Efficacy of AZD5363 When Combined With Paclitaxel in Breast Cancer Patients (BEECH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01625286
Recruitment Status : Active, not recruiting
First Posted : June 21, 2012
Last Update Posted : March 23, 2018
Sponsor:
Information provided by (Responsible Party):
AstraZeneca

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : January 28, 2017
  Estimated Study Completion Date : March 29, 2019

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 April 25, 2018